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patients after MitraClip therapy.
CATEGORIES STRUCTURAL: Valvular Disease: Mitral
KEYWORDS Mitraclip, Mitral regurgitation, Pulmonary hypertension
TCT-708
Progressive Mitral Annuloplasty with Implantation of an Adjustable
Complete Circumferential Ring: A Method for Chronic Cinching and Annular
Reduction
Yanping Cheng,1 Juan Grau,2 Gerard B. Conditt,1 Adrienne D. Meyers,1
Patricia Mount,1 Athanasios Peppas,1 Greg L. Kaluza,1 Juan Granada,1
Geng-Hua Yi1
1Cardiovascular Research Foundation, Orangeburg, NY; 2The Valley
Hospital, Ridgewood, NJ
BACKGROUND Mitral annuloplasty has been shown to be effective for
degenerative and functional mitral regurgitation (MR). However,
incidence of recurrent MR increases over time. We hypothesized that
progressive annuloplasty with implantation of adjustable ring might
not only decrease MR but also restrict further dilatation of the
annulus. This study aimed to evaluate the tissue healing reaction of
an implanted circumferential annuloplasty ring and the feasibility of
progressive cinching of the ring to reduce the diameter of the mitral
annulus in a sheep model.
METHODS The multi-element circumferential ring with eight anchors
(Cardiac Implants, Tarrytown, NY) was implanted to the circumfer-
ence of the mitral annulus near the base of the leaﬂets in 4 sheep via
open-heart procedure under cardiopulmonary bypass (CPB) support.
A mechanical cinching actuator attached to the ring was passed
through the interatrial septum and placed in the superior vena cava.
Cinching mechanism and gross histological evaluations were assessed
90 days post operatively.
RESULTS The ring was successfully anchored on mitral annulus and
the animals recovered from CPB procedures. Follow-up echocardi-
ography after 90 days conﬁrmed devices in the intended position
without interference with mitral valve function. The ring was
cinched using the cinching wire extension and the annular diameters
and area were remarkably decreased (Figure). Histology examination
showed the anchors positioned vertically with completion of tissue
healing response of the rings. All device components were
incorporated within collagenous tissue in-growth except for the
internal cinching wire. No surface thrombi were found around the
cinching actuator.CONCLUSIONS In this ﬁrst feasibility study, surgical implantation of
the circumferential annuloplasty ring was safe and allowed for
chronic progressive cinching following completion of tissue healing
over 90 days. This ring may be an essential component of further
catheter-based therapeutics for mitral valve repair and replacement.
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BACKGROUND The lack of common physiological retention features
as well as the varying and challenging anatomy of the mitral valve
presents a signiﬁcant challenge for the development of transcatheter
mitral valve replacement system. This study aimed to evaluate the
feasibility of acute retention in the mitral position of current com-
mercial transcatheter aortic valves using a novel valve retention sys-
tem (daVingi Ring, Cardiac Implants, Tarrytown, NY) in a pig model.
METHODS The daVingi Ring was delivered below the annular level on
the left ventricle (LV) side of the mitral valve annulus via transapical
access and captured the leaﬂets with small-proﬁle anchors in 4 pigs.
Then, a transcatheter aortic valve was deployed within the daVingi
Ring in the mitral position. The position and function of the implanted
aortic bioprosthetic valve was conﬁrmed by angiography and echo-
cardiography. Animals were euthanized 1 hour after device implan-
tation for gross inspection.
RESULTS The daVingi Ring was successfully deployed below the
annulus of the mitral valve and captured the leaﬂets with the anchors
in all animals (Figure a). The transcatheter aortic valve was
successfully expanded into the ring within the mitral position
(Figure b) without LV outﬂow tract obstruction (Figure c) or
signiﬁcant paravalvular leak (Figure d). Gross examination showed
the implanted valve was deployed halfway through the daVingi Ring
with no damage to the papillary muscles or chordae tendineae.
CONCLUSIONS It is feasible to deploy and maintain a transcatheter
aortic valve in the optimal mitral position following transapical im-
plantation of the daVingi Ring in a pig model. This valve retention
system might provide an easy approach to enable delivery of existing
